Unternehmen	Aktie, %
Cellectar Biosciences, Inc.	4.27
Merrimack Pharmaceuticals, Inc.	3.78
TherapeuticsMD, Inc.	2.36
Spero Therapeutics, Inc.	1.98
Arbutus Biopharma Corporation	1.93
Keen Vision Acquisition Corporation Units	0.58
Homology Medicines, Inc.	0.51
Acasti Pharma Inc.	0.37
Delcath Systems, Inc.	0